All the interest seems to be in the newer treatments - I'm not sure our DEP® drugs trialed interest anyone anymore, especially given JF & Co. took over a decade to trial them .... certainly looking more and more obsolete as time passes ?
.... now where's that TGA approval for Viraleze that @Starlink claims is basically in the bag from the final decision on nasal spray containing Astodrimer Sodium ?
https://www.fiercepharma.com/pharma...-FierceBiotech&oly_enc_id=9706A0310367J1T
J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer
New COMPETITION for antiviral nasal sprays, page-31
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.006(6.06%) |
Mkt cap ! $41.81M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $42.85K | 414.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 247015 | 5 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |